Healthcare
Altima and Finance Wales back Acuitas with €1m+
Welsh medical company Acuitas Medical Limited has secured a funding round of just more than €1m from private and institutional investors including Altima Partners and Finance Wales. According to Acuitas, the funding round was oversubscribed.
2011 exits: trade sales almost triple in value
As the graph shows, the proportion of trade sales, the most common exit route, has not changed significantly between 2010 and 2011.
Axis invests in Industrias Hidráulicas Pardo
Axis Participaciones Empresariales has invested an undisclosed amount in hospital equipment manufacturer Industrias Hidráulicas Pardo, part of the Grupo HCS and a portfolio company of MCH Private Equity.
Baring exits Centro Inmunológico de Cataluna
Baring Private Equity Partners has completed the exit of medical diagnostics company Centro Inmunológico de Cataluna (CIC) through a trade sale to French medical diagnostics company Labco.
Waterland PE backs Omega Pharma take-private
Waterland Private Equity has backed the take private of over-the-counter pharmaceuticals company Omega Pharma.
Sentica's Arjessa Group bolts on Jokilaakson Perhekodit
Sentica's portfolio company, child welfare service provider Arjessa Group, has acquired trade player Jokilaakson Perhekodit (JP) in a share-swap.
Aravis and Proquest back Telormedix
Aravis Venture and Proquest Investments have invested CHF 7.5m in biotechnology company Telormedix.
BaltCap backs Labochema
BaltCap has completed an investment in pan-Baltic laboratory supplies and services provider Labochema Company Group. Financial details of the transaction remain undisclosed but investment was under €3m in exchange for a significant minority stake.
Fondo Italiano makes €20m investment in TBS
Fondo Italiano di Investimento has invested €20m in integrated clinical engineering and health services provider TBS Group. The public-private government-backed vehicle has acquired a 13.17% stake in the listed company through a capital injection of...
HTGF backs Eyesight & Vision
High-Tech Gründerfonds and Bayern Kapital have funded a first round of financing for Eyesight & Vision.
Nazca acquires majority stake in Grupo IMO
Nazca Capital has acquired a majority interest in Spanish radiotherapy services provider Grupo IMO via the purchase of shares and a capital injection.
HTGF and Bayern Kapital back GME
High-Tech Gründerfonds and Bayern Kapital have invested €750.000 in laser and light systems provider German Medical Engineering (GME).
Apax and Nordic Capital-owned Capio acquires three clinics
Apax Partners and Nordic Capital's portfolio company Capio AB has acquired the French Aguilera, and Swedish CFTK and Avesina clinics.
Mid Europa buys Teresa Fryda Laboratory
Mid Europa Partners has acquired Dr. n. med. Teresa Fryda Laboratorium Medyczne Sp. Z o.o. (“Fryda”) as part of its plans to consolidate the Polish laboratory market.
Carlyle Group's Marle International acquires Deloro Stellite
Marle International, a French medical equipment business backed by The Carlyle Group, has acquired ATS Sferic, the non-core medical division of Deloro Stellite, owned by Duke Street Capital.
Duke Street’s partial exit reaps 9x EBITDA
Deloro Stellite, the specialist engineering group owned by Duke Street Capital, has sold its non-core medical division, ATS Sferic, to French medical products business Marle International, backed by The Carlyle Group.
EMBL II holds first close on €40m
EMBL Ventures has held a first close of its second fund, EMBL Technology Fund II (ETF II), on €40m.
Imperial and SV Life Sciences inject £8m into TopiVert
Imperial Innovations Group plc and SV Life Sciences have invested £8m in startup company TopiVert.
FSN Capital exits Norlandia Care to founders
FSN Capital has sold portfolio company Norlandia Care back to its founders, The Adolfsen Group.
arGEN-X secures €27.5m series-B funding
OrbiMed Advisors and Seventure Partners have led the series-B funding round for Dutch biopharma firm arGEN-X.
Forbion's CircuLite raises $30m
Forbion Capital Partners portfolio company CircuLite has secured $30m series-D funding.
Sofinnova and Morningside back NuCana BioMed
Sofinnova Partners has led a series-A round for biopharmaceutical company NuCana BioMed alongside Morningside Ventures and other investors, with financing totaling £6.74m.
Forbion leads $26.5m round in Oxyrane
Forbion Capital has led a $26.5m series-D funding round for biopharmaceutical producer Oxyrane.
Sovereign's NFA up for sale
Sovereign Capital is currently receiving offers from private equity buyers for the National Fostering Agency (NFA), according to media reports.